Uncategorized

$NUGS Cannabis Inhalers Could Be the Next Asthma and Cancer Pain Med

Whole smoking is the most common administration method for medical cannabis, not all patients are willing or able to use this method. For example, those who have respiratory challenges like asthma are unable to smoke cannabis because it may aggravate their condition. Terminally ill patients may also find it hard to smoke marijuana as part of their treatment. For such patients, two Israeli companies have teamed up to develop cannabis inhalers through which they can take their medication.

The two firms are Panaxia Pharmaceuticals and Rafa Pharmaceuticals. The two companies are working together to bring marijuana inhalers to the market so that patients have one more way to get their medication.

For now, the companies are targeting asthma and the pain suffered by cancer patients. The companies hope to avail an administration mode that will bring quick relief to cancer pain or respiratory distress resulting from asthma symptoms.

This administration mode may easily gain acceptance in the market for several reasons.

First, inhalers aren’t a new mode of administering medication to patients. Asthma sufferers carry them around, so it would not be hard for them to switch to the cannabis version.

Secondly, it is possible to determine what precise dose of cannabis a patient should receive when using inhalers since the patient can be told to inhale a given number of times at stipulated intervals in order to get the right dose of cannabis into the body. Medical practitioners can therefore easily see cannabis as medicine if its dosage can be controlled.

Additionally, inhalation can provide faster therapeutic outcomes when compared to other modes, such as consuming cannabis edibles. This is precisely why asthma sufferers often carry an inhaler so that they can use it and see results faster when an asthma attack occurs.

At the moment, the innovators are conducting clinical trials together with the Israeli Ministry of Health in order to ascertain whether the product is ready to hit the market, or some kinks remain which need to be resolved.

Meanwhile, the companies have decided to start a marketing drive for the inhalers while the clinical trial is ongoing.

The plan is to avail the inhalers on the Israel market later this year. Only patients with a doctor’s prescription will be able to access the product. It is not yet clear when the two companies will start exporting their invention to the rest of the world. Remember, the Israeli parliament passed a law towards the end of last year allowing companies that have been licensed by the state to export medical marijuana.

Youngevity International, Inc. (NASDAQ: YGYI) and Cannabis Strategic Ventures, Inc. (OTC: NUGS) congratulate the two Israeli companies for finding a solution to administering medical cannabis to patients who are unable to use the modes that are currently available on the market.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Monday, April 15th, 2019 Uncategorized Comments Off

$LXRP Engages Oak Hill Financial Inc. to Provide Investor Relations Services

Kelowna, BC / April 15, 2019 – Lexaria Bioscience Corp. (CNSX: LXX) (OTCQB: LXRP) (“Lexaria” or the “Company”) announces it has retained Oak Hill Financial Inc. (“Oak Hill”) to provide investor relations services to the Company in compliance with regulatory guidelines.

Oak Hill is a Toronto-based firm that develops strategic platforms for its clients that are utilized to gain exposure and recognition in the capital markets. Oak Hill provides asset management, capital market and investor relations services. Its team has marketed corporate issuers ranging in market cap from $10M to $1B in a variety of different sectors to the Canadian retail brokerage channel, family offices and institutional networks. Oak Hill’s team has experience across equity capital markets, equity research, portfolio management, institutional equity sales, and traditional investor relations – resulting in tailored and highly collaborative solutions.

Oak Hill will work closely with Lexaria to develop and deploy a comprehensive capital markets strategy and campaign. Activities will include providing an investor relations program catering to retail investors, marketing services and an ongoing client services program.

About Lexaria

Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and higher effectiveness of lipophilic active molecules. Lexaria has multiple patents pending in over 40 countries around the world and has patents granted in the USA and in Australia for utilization of its DehydraTECH(TM) delivery technology. Lexaria’s technology provides increases in intestinal absorption rates; more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs),nicotine and other molecules.

www.lexariabioscience.com

For regular updates, connect with Lexaria on Twitter https://twitter.com/lexariacorp

and on Facebook https://www.facebook.com/lexariabioscience/

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Bioscience Corp.

Alex Blanchard, Communications Manager

(250)765-6424 Ext 202

Or

NetworkNewsWire (NNW)

www.NetworkNewsWire.com

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements, including but not limited to: that any additional stock warrants or stock options will be exercised. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition, the patent application and approval process and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that existing capital is sufficient for the Company’s needs or that it will be able to raise additional capital. There is no assurance that Lexaria will successfully complete any other contemplated or existing technology license agreements; or that results from any studies will be favorable or in any way support future business activities of any kind. Scientific R&D is often unpredictable and unanticipated results could emerge from any study and have a material impact. There is no assurance that any planned corporate activity, scientific study, R&D, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any of Lexaria’s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). TurboCBDTM, DehydraTECHTM technology and ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

Monday, April 15th, 2019 Uncategorized Comments Off

$GNPX at Forefront to Advance Innovative Developments in Fight Against Lung Cancers

Clinical-stage gene-therapy company Genprex (NASDAQ: GNPX) is at the forefront to advance innovative developments in the war against lung cancers, testing its trademarked Oncoprex immunogene therapy. A recent article discussing this reads, “Oncoprex’s phase I and II clinical-stage trial therapies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities (http://nnw.fm/aJtE9). The company has a portfolio of 30 issued patents and two more pending, and it is also conducting preclinical research to help identify which patients will be most likely to benefit from its gene therapies and which additional cancer drugs will be the most synergistic with Oncoprex.”

To view the full article, visit: http://nnw.fm/6grZu

About Genprex Inc.

Genprex Inc. is a clinical-stage, gene-therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex(TM) immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. For more information, visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://nnw.fm/GNPX

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Monday, April 15th, 2019 Uncategorized Comments Off

$GGBXF Files to Accelerate Expiration of Aphria Bid

COLUMBUS, OH, April 15, 2019

This press release is for informational purposes only and does not constitute an offer to buy or sell, or a solicitation of an offer to buy or sell, any securities. The offer to acquire Aphria Shares and to issue securities of the Green Growth is made solely by, and subject to the terms and conditions set out in, the Offer to Purchase and Circular, as varied by the Notice of Variation, and letter of transmittal and notice of guaranteed delivery.  See also “Notice to U.S. Holders of Aphria Shares” below.

GGB initiates 27.3 million share buyback from GA Opportunities which would result in the cancellation of 13% position

COLUMBUS, OH, April 15, 2019 - Green Growth Brands Inc. (“Green Growth” or the “Company“) (CSE: GGB) today announced that it has reached an agreement with Aphria Inc. (“Aphria“) to shorten the expiry time for acceptance of its formal offer (the “Offer“) to acquire all of the issued and outstanding common shares (the “Aphria Shares“) of Aphria (TSX: APHA and NYSE: APHA) from 5:00 p.m. (Toronto time) on May 9, 2019 to 5:00 p.m. (Toronto time) on April 25, 2019 (the “Expiry Time“).

The Company has also agreed to repurchase 27,300,000 of its common shares held by GA Opportunities Corp. (“GAOC“) for aggregate consideration of C$89 million, or a significantly discounted price of approximately C$3.26 per share (the “Repurchase“).  The aggregate consideration will be paid through a combination of cash and a secured promissory note (the “Note“) payable in 6 months from the closing of the Repurchase.  Green Growth has granted a security interest to GAOC to secure its obligations under the agreement relating to the Repurchase and the Note.  GAOC will continue to hold 200,000 Green Growth shares following completion of the Repurchase, which shares will be subject to a 12 month lock-up agreement on customary terms with 16,666 shares released per month.  As GAOC will hold less than 5% of the issued and outstanding Green Growth common shares on closing of the Repurchase (on a non-diluted basis), it will no longer have rights under the Nomination Rights Agreement with the Company.

The Company’s Repurchase of its common shares will allow for the elimination of the second largest block of its outstanding shares at a price that is significantly below the market price.

‘We are pleased to be buying back 27,300,000 shares owned by GA Opportunities significantly below the market price and the expected sale of our toehold position of 3 million shares of Aphria, all of which will benefit our shareholders,” said Peter Horvath, CEO of Green Growth Brands.  “We are bringing our offer to an end on good terms with Aphria and are excited to turn our focus to our CBD personal care and retail cannabis businesses. We are actively continuing to review other partnerships and M&A opportunities to accelerate the build out of our company.”

The Company is entitled to shorten the time period for acceptance of the Offer as Aphria today issued a deposit period news release (within the meaning of National Instrument 62-104 – Take-Over Bids and Issuer Bids (NI 62-104)) stating “Aphria has agreed to reduce the initial deposit period of the bid to 92 days from January 23, 2019″.  In connection with the acceleration of the Offer, Aphria and the Company have also agreed to a mutual 12 month standstill period and have agreed to enter into discussions involving a potential commercial arrangement between the parties.  All other terms and conditions of the Offer remain unchanged.

A Notice of Variation with respect to the Offer will be filed with the Canadian securities regulators, will be mailed to holders of Aphria Shares and will be available for review on SEDAR at www.sedar.com.  The Notice of Variation should be read in conjunction with the original offer to purchase and circular, dated January 22, 2019 (the “Offer to Purchase and Circular“) and the other documents accompanying the Offer to Purchase and Circular.

Both Green Growth and Aphria have determined that the accelerated expiry of the Offer is, in lieu of proceeding with the Offer for an extended period of time, in their respective best interests. Both Green Growth and Aphria agree that the proposed transaction, as described in more detail in the Notice of Variation, is superior to the Offer.  If the Offer is successful, then the proposed transaction among Green Growth, Aphria and GAOC will terminate and not be completed.

Relief was granted to Green Growth on April 12, 2019 by the Ontario Securities Commission (the “Relief“) from certain formal requirements relating to issuer bids in connection with completing the Repurchase. The Repurchase is expected to occur in early May after the expiry of the Offer and is conditional on the satisfaction of the terms of the Relief, including that the price at which the Repurchase is completed is not greater than the market price of the common shares (calculated in accordance with NI 62-104).  The Company has obtained written consents for the Repurchase from shareholders holding, in the aggregate, a majority of the outstanding voting shares of the Company, other than voting shares held by interested parties, related parties of interested parties and their joint actors.

The Board of Directors of the Company has received an opinion from the Company’s financial advisor that the Repurchase is fair, from a financial point of view, to the Company’s shareholders (other than GAOC).

Based on the closing price of $3.86 per Green Growth Share on the CSE as of April 12, 2019, the last trading day prior to the date of the Notice of Variation, the implied Offer Consideration would be $6.07 per Aphria Share (being a 54.8% discount to the Aphria Shares’ closing price of $13.41 on the Toronto Stock Exchange on April 12, 2019).

Advisors

Legal counsel to Green Growth was Norton Rose Fulbright Canada LLP and Canaccord Genuity Corp. was financial advisor for the Offer. Kingsdale Advisors was Green Growth’s strategic shareholder and communications advisor and depositary.

Cautionary Statement in Forward-Looking Information

This press release contains certain statements and information which constitute forward-looking statements or “forward-looking information” within the meaning of applicable securities laws, including “future-oriented financial information” with respect to prospective financial performance, financial position, cash flows and other financial metrics that are presented either as a forecast or a projection. Wherever possible, forward-looking information can be identified by the expressions “seeks”, “expects”, “intends”, “believes”, “estimates”, “will”, “plans”, “may”, “anticipates,” “target” and similar expressions (or the negative of such expressions). The forward-looking statements or forward-looking information are not historical facts, but reflect the current expectations of Green Growth regarding future results or events and are based on information currently available to it. The forward-looking events and circumstances discussed in this release include, but are not limited to, (i) the expiry of the Offer; (ii) the completion of the Repurchase; and (iii) the entering into of a commercial arrangement with Aphria. All material assumptions used in making forward-looking statements are based on Green Growth’s knowledge of its business and the business of Aphria, and, in some cases, information supplied by third parties, including the public disclosure made by the Company. Certain material factors or assumptions include, but are not limited to, (i) the current business conditions and expectations of future business conditions and trends affecting Green Growth and Aphria, including the U.S. and Canadian economies, the cannabis industry in Canada, the United States and elsewhere, and capital markets, and (ii) that there have been no material changes in the business, affairs, capital, prospects or assets of the Company, except as publicly disclosed by the Company before the date hereof. All forward-looking statements and forward-looking information in this press release are qualified by these cautionary statements. Green Growth believes that the expectations reflected in forward-looking statements and forward-looking information are based upon reasonable assumptions; however, Green Growth can give no assurance that the actual results or developments will be realized by certain specified dates or at all. Forward-looking statements and forward-looking information are subject to a number of risks and uncertainties that could cause actual results or events to vary materially from current expectations. In addition to risks noted elsewhere in this news release, material risks include, but are not limited to, (i) the risk that the proposed transaction involving Aphria and GAOC will not have the anticipated effect on Green Growth or its business or will not be consummated for any reason; (ii) the risk that the conditions to the Offer will not be met, or met on a timely basis, or that the transaction will not be consummated for any other reason, (iii) changes in general economic conditions in Canada, the United States and elsewhere, (iv) changes in operating conditions (including changes in the regulatory environment) affecting the cannabis industry, and (v) fluctuations in currency and interest rates, availability materials and personnel.  Readers, therefore, should not place undue reliance on any such forward-looking information. Further, forward-looking statements and forward-looking information speaks only as of the date hereof. Green Growth disclaims any intention and assumes no obligation to update or revise any forward-looking statements or forward-looking information, even if new information becomes available, as a result of future events or for any other reason, except to the extent required by applicable securities laws.

Notice to U.S. Holders Aphria Shares

Green Growth has filed with the Securities and Exchange Commission (the “SEC“) a Registration Statement on Form F-10 (the “Registration Statement“) under the United States Securities Act of 1933, as amended (together with the rules and regulations promulgated thereunder, the “U.S. Securities Act“) pursuant to the multi-jurisdictional disclosure system adopted by the United States, a Tender Offer Statement on Schedule 14D-1F (the “Tender Offer Statement“) under the United States Securities Exchange Act of 1934, as amended (together with the rules and regulations promulgated thereunder, the “U.S. Exchange Act“), this Notice of Variation and other documents and information. Green Growth URGES INVESTORS AND APHRIA SHAREHOLDERS TO READ THE REGISTRATION STATEMENT, THE TENDER OFFER STATEMENT, THE ORIGINAL OFFER TO PURCHASE AND CIRCULAR, THIS NOTICE OF VARIATION AND ANY OTHER RELEVANT DOCUMENTS FILED OR TO BE FILED WITH THE SEC IN CONNECTION WITH THE OFFER AND SALE OF GREEN GROWTH SHARES AS THOSE DOCUMENTS BECOME AVAILABLE, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THOSE DOCUMENTS, BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION. Investors and Aphria Shareholders will be able to obtain the documents free of charge at the SEC’s website, www.sec.gov. In addition, documents filed with the SEC by Green Growth will be available free of charge from Green Growth. You should direct requests for documents to Kingsdale, 130 King St West, Suite 2950, Toronto, ON M5X 1K6, Toronto, North American Toll Free Phone: 1-866-851-3214, outside North America Phone: 416-867-2272. To obtain timely delivery, such documents should be requested no later than five (5) business days before the Expiry Time.

Green Growth is a foreign private issuer and permitted to prepare the offer to purchase and takeover bid circular and related documents in accordance with Canadian disclosure requirements, which are different from those of the United States. Green Growth prepares its financial statements in accordance with International Financial Reporting Standards applicable to Canadian public companies formulated by the International Accounting Standards Board, and they may be subject to Canadian auditing and auditor independence standards. These financial statements may not be comparable to the financial statements of United States companies.

Shareholders of Aphria should be aware that the disposition of their Aphria Shares and the acquisition of the Company’s shares may subject them to tax consequences both in the United States and in Canada. The Offer to Purchase and Circular may not describe these tax consequences fully. Aphria shareholders should read any tax discussion in the Offer to Purchase and Circular, and are also urged to consult their tax advisors.

The enforcement by Aphria Shareholders of civil liabilities under U.S. federal securities laws may be affected adversely by the fact that Green Growth was amalgamated under the Laws of Ontario, and Aphria was amalgamated under the Laws of Ontario, that some or all of their respective officers and directors may be residents of a foreign country, that some or all of the experts named herein may be residents of a foreign country and that all or a substantial portion of the assets of Green Growth and Aphria and said persons may be located outside the United States. Aphria Shareholders may not be able to sue Green Growth or Aphria or their officers or directors in a foreign court for violations of U.S. securities laws. It may be difficult to compel Green Growth or Aphria or their respective affiliates to subject themselves to the jurisdiction of a court in the United States or to enforce a judgment obtained from a court of the United States.

NEITHER THE SEC NOR ANY STATE SECURITIES REGULATOR HAS OR WILL HAVE APPROVED OR DISAPPROVED GREEN GROWTH’S SHARES OFFERED IN THE OFFERING DOCUMENTS, OR HAS OR WILL HAVE DETERMINED IF ANY OFFERING DOCUMENTS ARE TRUTHFUL OR COMPLETE. ANY  REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

GREEN GROWTH’S SHARES HAVE NOT BEEN REGISTERED OR OTHERWISE QUALIFIED FOR OFFER AND SALE IN CERTAIN U.S. STATES WHERE HOLDERS OF APHRIA SHARES RESIDE AND NO SUCH OFFER TO SELL OR SALE, OR SOLICITATION OF AN OFFER TO BUY MAY BE MADE IN SUCH U.S. STATES.

Aphria shareholders should be aware that, during the period of the Offer, Green Growth or its affiliates, directly or indirectly, may bid for or make purchases of the securities to be distributed or to be exchanged, or certain related securities, as permitted by applicable laws or regulations of Canada or its provinces or territories.

SOURCE Green Growth Brands

Media Contact: Ian Robertson, Executive Vice President, Communication Strategy, Kingsdale Advisors, Direct: 416-867-2333, Cell: 647-621-2646, Email: irobertson@kingsdaleadvisors.com; Investor Contact: Peter Horvath, CEO, Green Growth Brands Inc., Phone: 614-508-4222Copyright CNW Group 2019

Monday, April 15th, 2019 Uncategorized Comments Off

$YGYI to Host Conference Call Reviewing 2018 Financial Results

Leading omni-direct lifestyle company Youngevity International Inc. (NASDAQ: YGYI) this morning announced that it will host a conference call on Tuesday, April 16, 2019, at 1:00 p.m. ET to discuss its financial results for the quarter and year ended December 31, 2018. Per the update, the call will be hosted by Youngevity’s senior management, including Chairman and CEO Steve Wallach and President and CFO Dave Briskie. Interested parties can attend the call by clicking this link at least 15 minutes prior to the start time, or by dialing 206-402-0100 and entering access code 634174# at least five minutes prior to the start of the call. Additionally, an audio recording will be available for replay shortly after the conclusion of the call on the company’s corporate website.

To view the full press release, visit http://nnw.fm/L4Mw9

About Youngevity International Inc.

Youngevity International Inc. is a multi-channel lifestyle company operating in three distinct business segments – a commercial coffee enterprise, a commercial hemp enterprise and an omni direct selling platform. The company features an international selling network and has assembled a virtual Main Street of products and services under one corporate entity. YGYI offers products from the six top-selling retail categories, including health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry and innovative services. For more information, visit the company’s website at www.YGYI.com

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://nnw.fm/YGYI

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Monday, April 15th, 2019 Uncategorized Comments Off

$NETE Revenues Grow in 2018, Total Processing Volume Also Goes Up

  • Sustainable growth in revenue mainly stemmed from the North American transaction solutions segment
  • The total processing volume also grew to reach $3.3 billion, most of which was covered by North America
  • Net Element subsidiaries like Aptito have been contributing to the U.S. market growth with the provision of cost-efficient, tailored and innovative niche services

Net Element Inc. (NASDAQ: NETE) recently announced solid financial growth in 2018. The company’s revenue over the year went up to $65.8 million, marking an increase of 10 percent on an annual basis. Growth through the company’s North American transaction solutions segment was the primary driver for the strong results, as the company’s management announced in an earnings conference call on April 2, 2019 (http://nnw.fm/sF47f).

The North American transaction solutions segment experienced annual growth of 16 percent in 2018. The United States accounted for 90 percent of the overall revenue, while international revenue contributed…

Read more »

NOTE TO INVESTORS: The latest news and updates relating to NETE are available in the company’s newsroom at http://nnw.fm/NETE

 

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, April 12th, 2019 Uncategorized Comments Off

$NUGS Mounting Cannabis Business Demand for Outsourced Employmcent Services

Los Angeles, California-based cannabis firm Cannabis Strategic Ventures’ (OTC: NUGS) subsidiary BudHire is ideally positioned to take advantage of the rising demand for outsourced personnel solutions. A recent article discussing NUGS reads, “Supporting this rapidly growing industry is the prime strategy of Cannabis Strategic Ventures. Among the company’s subsidiaries is the aptly named BudHire, an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations. Research conducted by Glassdoor shows that cannabis job openings are increasing rapidly, with 1,512 open in the United States during December 2018 — a 76% increase over the same period in the previous year. More than 50% of those jobs are for professional and technical workers from a variety of fields, Glassdoor found (http://nnw.fm/s94GJ). . . . Cannabis Strategic Ventures and BudHire utilize a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire brand, Cannabis Strategic Ventures offers temporary, seasonal and permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry (http://nnw.fm/cqxY3).”

To view the full article, visit: http://nnw.fm/RU2gg

About Cannabis Strategic Ventures Inc.

Cannabis Strategic Ventures is a Los Angeles-based firm that incubates, develops and partners with category leaders within the cannabis sector. The firm’s NUGS brand experience provides mentorship and a range of essential services to emerging and existing cannabis consumer brands. The company recently completed a name and symbol change from Cascade Energy Inc. Cannabis Strategic Ventures is publicly traded on the U.S. Over-the-Counter Market with the stock symbol NUGS. For more information, visit the company’s website at www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://nnw.fm/NUGS

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, April 12th, 2019 Uncategorized Comments Off

$GNPX NetworkNewsAudio Broadcast, Gene Therapy Treatment for Cancer

New York, New York–(April 12, 2019) – Genprex Inc. (NASDAQ: GNPX)announces the availability of a NetworkNewsAudio broadcast titled, “Potential Blockbuster Gene Therapy Programs to Watch in 2019.”

To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/j1WMs

To read the full editorial, visit: http://nnw.fm/YC9iq

Genprex already has over 30 issued patents for its platform technologies. The company’s promising pipeline currently includes a phase I/II clinical trial underway to evaluate intravenous Oncoprex immunogene therapy in combination with another cancer drug, Tarceva, and pre-clinical research of the combination of Oncoprex immunogene therapy with immunotherapies.

Gene therapy programs may be on the cusp of curing the incurable, and the companies that deliver these medical miracles are in an ideal position to reap a bonanza of recognition and rewards. Given the promise of Genprex’s pipeline of cancer killers with global blockbuster potential, the company certainly appears to be one to watch.

About Genprex Inc.

Genprex Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. Visit the company’s web site at www.genprex.com or follow Genprex on Twitter at twitter.com/genprex, Facebook at facebook.com/genprexinc, and LinkedIn at linkedin.com/company/genprex.

About NetworkNewsAudio

NetworkNewsAudio (NNA) , a NetworkNewsWire (NNW) Solution, allows you to sit back and listen to market updates, CEO interviews and a Company AudioPressRelease (APR). These audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio (NNA) can assist your company by cutting through the overload of information in today’s market, NNA brings its clients unparalleled visibility, recognition and brand awareness. NetworkNewsWire (NNW) is where news, content and information converge. NetworkNewsWire (NNW) is a comprehensive provider of news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW has the unparalleled ability to reach a wide audience of investors, consumers, journalists and the general public with an ever-growing distribution network of more than 5,000 key syndication outlets across the nation.

For more information, visit: www.NetworkNewsAudio.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

Friday, April 12th, 2019 Uncategorized Comments Off

$RIV.V $RIV.V $CNPOF Kentucky Advances Medical Marijuana Bill

With a total of 33 states so far approving medical marijuana, yet another state appears on the road to legal medical adoption. For the first time ever, the Kentucky legislative panel has advanced a medical marijuana bill.Strong endorsement of medical marijuana legalization has added momentum to the cannabis growth and CBD derived products markets in U.S. states where companies see the trend as a next step to national growth, including providers like General Cannabis Corp (OTC: CANN), Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF), and MedMen Enterprises Inc. (OTC: MMNFF) (CSE: MMEN).

Besides the growing medical application of cannabis, the CBD and hemp-based products business is also gaining strength. The Yield Growth Corp. is one of the early innovators in the space getting attention for its broad offering. The Yield Growth Corp. (CSE: BOSS) has developed a line of wellness and beauty products that make the most of what the hemp plant can legally offer in almost any country, as well as offering the opportunity to infuse those products with THC or CBD if and where they become legal.

The strategy of using legal products and developing brands as a gateway to the products that require legalization for inclusion of THC or CBD is seen by the industry as a move to broaden the appeal of the products. Many of the products will become well-known brands before ever including any of the currently restricted ingredients.

The Bill Being Advanced in Kentucky

The bill being forwarded in Kentucky has been a while in the making and would allow doctors to prescribe marijuana to treat certain medical conditions. The bill has now officially passed out of a state legislative panel – a bit of a feat in itself.

As actual legislation, the bill has a long way to go to actually pass out of the legislature. But what’s important to note is that this the move equates to the very first time that a medical marijuana proposal has advanced in the statehouse of Kentucky. Many see this as a symbol of the shift in perception about medical marijuana use.

As intended, House Bill 136 would create a state-regulated system that would include groups involved in growing, processing, dispensing and testing marijuana. Licensed doctors would be able to prescribe marijuana for their patients who have specific of medical conditions with known effective treatment. These includes things like Crohn’s disease, cerebral palsy, epilepsy, certain kinds of nausea and chronic pain, such as back pain, amongst others.

One of the bill’s sponsors, Rep. Diane St. Onge (R), has clarified that the legislation had been changed from previous versions in order to be more accessible and attractive to voters.

“We have been very willing to work with the stakeholders in this arena to try to put forth the best possible bill under the most stringent guidelines for our people,” St. Onge said.

The bill would allow patients to buy the marijuana plant in order to make their own tinctures, oils or edibles, but it bans “combustion” of the plant. Earlier versions of the bill were expected to allow patients to smoke marijuana or grow their own cannabis plants, but those provisions have now been removed.

Topicals and Natural Products Have an Easier Road

No matter the outcome of bills like the one now before the Kentucky legislature, it’s clear that topical and natural products infused with formulations akin to CDB or cannabis have the easier road to clearance. The infused and naturals sector is creating a whole new sub-category in the multibillion-dollar beauty and wellness markets. These include new and natural formulations for common categories.

An early mover in this sector is The Yield Growth Corp. who are launching into markets where medical marijuana is or may become legalized. The Yield Growth Corp. has several major brands to generate an entire portfolio in the developing CBD space. Under the brand Urban Juve, they are launching a set of nearly 50 products this year. Based in Canada, the company has already completed 26 Health Canada registrations. According to management, the initial launch will consist of base products only, but all of their products may offer CBD infused or THC infused versions in the future.

Yield also has granted CROP Infrastructure Corp. the rights to distribute Urban Juve products in Italy. CROP Infrastructure grows, produces, and sells cannabis products with a solid foothold in California, Nevada, and Washington State. They also recently expanded into Jamaica acquiring over 200,000 square feet of fertile cropland.

For Yield, a fertile market like Kentucky could offer a place where It can sell its base products nearly and then capitalize on a market that could potentially legalize use of THC or CBD.

A Ways to Go but Still A Sign of the Times

For Kentucky, its new bill hurdled the first step of the legislative process by passing out of the House Judiciary Committee with a successful vote of 16 in favor and reported one against, with one pass ballot.

In order to pass fully, the measure would need to advance quickly through the full House and Senate especially since there are very few working days left in this legislative session.

It’s significant that earlier versions of the bill would have allowed patients to grow up to 12 plants and had no ban on smoking, but those provisions are now removed. That meant a new tact that gives the bill some headway. There are 33 other states that have legalized medical marijuana at present. Geographically speaking Kentucky is in some good company with neighboring states of West Virginia, Ohio, Illinois and Missouri already having approved the medical application of weed.

Companies with pathways to serving American, Canadian, and global markets are likely to see the biggest gain from moves to legalization of marijuana and hemp products used in both medical and recreational applications. These companies include:

General Cannabis Corp (OTC: CANN) provides a whole host of ancillary services to producers and businesses in the marijuana industry, ranging from real estate, consulting, business development and even security. The Denver, Colorado-based company even owns a specialty cannabis lifestyle apparel under the brand Chiefton Supply Co.

Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) pursues investment and operating opportunities in the emerging global cannabis sector. Canopy Rivers is at a unique advantage due to the strategic partnership and cornerstone investment from Canopy Growth Corporation. Canopy Rivers works collaboratively with Canopy Growth to identify strategic counter-parties seeking financial or operating support.

MedMen Enterprises Inc. (OTC: MMNFF) (CSE: MMEN) operates as a cannabis company in the United States. It owns and operates 18 licensed cannabis facilities in cultivation, manufacturing, and retail located in California, Nevada, and New York.

For a more information about The Yield Growth Corp. and CBD-based businesses, see the article at: http://usanewsgroup.com/2019/01/15/the-sleeping-giant-for-2019-just-woke-up-and-its-a-game-changer-for-investors-looking-to-diversify-into-a-multi-billion-dollar-sector/

USA News Group

http://usanewsgroup.com

info@usanewsgroup.com

Legal Disclaimer/Disclosure:

While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter/report/commentary piece/article is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Furthermore, it is certainly possible for errors or omissions to take place regarding the profiled company, in communications, writing and/or editing.

Nothing in this publication should be considered as personalized financial advice. We are not licensed under any securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. Equity Insider is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for The Yield Growth Company (“TYGC”) advertising and digital media from the company. There may be 3rd parties who may have shares of BOSS and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. The owner/operator of MIQ has purchased shares of BOSS through a private placement and does not intend on selling any shares within 72 hours of this updated publication date (December 6, 2018) after such point we reserve the right to buy and sell shares in the open market, no further notice will be given. We also expect further compensation from the company and will partake in future private placements of BOSS as an ongoing effort to gain exposure for the company. No further notice will be given, but let this serve as notice that we are not independent in our opinion and this is a major conflict of interest as to our ability to remain objective in our communication. Always consult a licensed financial advisor before making any sort of investment decision. Due to the volatility of the capital markets, and especially those that are thinly traded at lower prices, it is very easy to lose some, if not all, of your investment. Caution needs to be taken when making any sort of investment decision.

By reading this communication, you agree to the terms of this disclaimer, including, but not limited to: releasing MIQ, its affiliates, assigns and successors from any and all liability, damages, and injury from the information contained in this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

Friday, April 12th, 2019 Uncategorized Comments Off

$TGOD $TGODF California’s Cannabis Home Delivery Policy Faces Legal Challenge

Recently, California passed a rule to allow the statewide delivery of cannabis. However, a legal battle between the state and 25 cities is brewing after the cities went to court to have that rule overturned.

When California legalized marijuana, local governments were given the right to decide whether cannabis businesses and sales would be permitted in their jurisdictions and the conditions under which such operations could be permitted.

Many local governments exercised their right and opted to ban recreational cannabis from their jurisdictions. The new rule allowing cannabis retailers to deliver cannabis to “any address” within the state has angered the local authorities and 25 of them have gone to court over the matter since the rule would, in effect, render their position to ban cannabis ineffective.

At the core of this lawsuit is a desire to determine whether it is the state regulators in charge, or the local authorities where marijuana is cultivated and sold.

Marijuana companies and consumers advocated for the passing of the rule allowing the delivery of cannabis in the state because there were large “marijuana deserts” created by the action of local authorities that banned marijuana in their jurisdictions.

Those “deserts” made it difficult for people, especially frail patients, in those areas to access cannabis and yet the products were legal in the state.

Prop 64, the law under which cannabis became legal in California, indicates that cannabis can be delivered anywhere in the state by employees of a licensed cannabis retail business.

The cities that have gone to court therefore seem to be interested in establishing whether that provision overrides their power to restrict cannabis businesses from operating within their jurisdictions.

The state insists that the delivery rule is merely reinforcing what is already in the law while the cities argue that cannabis businesses are trying to circumvent the ban imposed by local governments. The cities insist that the deliveries should only be to the areas where the local governments have consented to the operation of cannabis businesses in their areas.

Currently, California is the largest cannabis market within the U.S., but many residents have been finding it hard to buy marijuana because of the ban imposed by several local authorities. This case is therefore going to be a landmark one since the ruling may make a definitive determination of how the cannabis industry in the state will operate.

The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), Therma Bright, Inc. (TSX.V: THRM) (OTC: THRBF) and the entire marijuana industry are watching with bated breath to see how the court will rule on this latest source of friction between the state and the local governments.

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Friday, April 12th, 2019 Uncategorized Comments Off

$YGYI Subsidiary Expands through Acquisition of Land

Khrysos Industries, a subsidiary of leading omni-direct lifestyle company Youngevity International (NASDAQ: YGYI), recently acquired 45 acres of land for research and development. A recent article discussing the company reads, “The company, which has been named among the ‘Top 100 Global Direct Selling Companies,’ holds a diversified portfolio of goods and services in a variety of markets. Specifically, Youngevity offers products in the top eight most profitable retail categories of health and nutrition, home and family, food and beverage (including coffee), spa and beauty, fashion, essential oils, photo and innovative services. Additionally, the company is seeking inroads to the newly profitable cannabis market. Through all of its endeavors, Youngevity assists individuals in embracing a healthy and empowered lifestyle. . . . One of Youngevity’s wholly owned subsidiaries, Khrysos Industries, is looking to substantially expand through its acquisition of a 45-acre tract of land. Plans for this tract include a research and development facility focused on hemp-plant genetic research, a five-acre greenhouse and 20 acres of farmable land. These investments are intended to increase specific yields of certain cannabinoids, which will foster the production of tissue culturing and quality hemp-seed production.”

To view the full article, visit: http://nnw.fm/2ojMC

About Youngevity International Inc.

Youngevity International is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that also offers e-commerce and the power of social selling. Assembling a virtual main street of products and services under one corporate entity, YGYI offers products from the eight top-selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, fashion, essential oils, photo, as well as innovative services. The company was formed in the course of the summer 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company (now part of the company’s food and beverage division). For more information, visit the company’s website at www.YGYI.com.

NOTE TO INVESTORS: The latest news and updates relating to YGYI are available in the company’s newsroom at http://nnw.fm/YGYI

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Friday, April 12th, 2019 Uncategorized Comments Off

$VVCIF $VIVIO to Post Q4, Full Year 2018 Results on April 30

Ontario-based VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), a leading provider of first-class cannabis products and services to the medical and adult-use markets, announced on Wednesday that it intends to post the company’s financial and operating results for the fiscal fourth quarter and full year 2018 before the markets open on April 30, 2019.

To view the full press release, visit: http://nnw.fm/n0kHk

About VIVO Cannabis(TM)

VIVO Cannabis(TM), based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licenses from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical(TM), FIRESIDE(TM), Canna Farms(TM) and Lumina(TM). In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine app. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally. For more information, visit the company’s website at www.VivoCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://nnw.fm/VVCIF

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Thursday, April 11th, 2019 Uncategorized Comments Off

$TGOD $TGODF U.S. Currently 2nd To China In Hemp Revenues

Palm Beach, FL – April 11, 2019 – In recent industry reports, China led all countries with nearly $1.2 billion USD in hemp sales in 2018, followed by the United States ($1.0 billion), Europe ($980 million) and South and Central America ($220 million). A recent report from an independent, technology-driven analytics company specializing in the cannabis industry stated that: “… the global hemp industry reached $3.7 billion USD in retail sales in 2018, with an annual growth rate of 15% driven by continued strength in Chinese textiles, European industrials, Canadian foods, and the U.S. hemp-derived CBD market.” This report is the first in-depth, quantitative and fact-based analysis of the global hemp industry since the United States’ 2018 Farm Bill and Canada’s Cannabis Act passed; two groundbreaking changes in North America that dramatically re-shaped the entire hemp industry.” By 2020, (the report data says) estimates the global market will reach $5.7 billion USD across all markets, representing a three-year compound annual growth rate (CAGR) of 17.5%.  The U.S. market, however, is positioned to grow under the 2018 Farm Bill, with an estimated $2.6 billion projected in sales by 2022, with $1.3 billion in sales estimated for hemp-derived CBD products by 2022. “As regulatory barriers diminish in the months and years ahead, businesses will continue to expand the ways in which hemp is utilized, especially across medicinal and industrial applications,” said (the author).  Active companies in the markets this week include The Yield Growth Corp. (CSE:BOSS) (OTC:BOSQF), The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTC: TGODF), OrganiGram Holdings Inc. (TSX-V: OGI) (OTC: OGRMF), The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTC: SPRWF), MedMen Enterprises Inc. (CSE: MMEN) (OTC: MMNFF)

The report concluded: “The U.S. hemp industry is set to boom under the 2018 Farm Bill. American farmers have a new crop, and consumers are seeing an explosion of new and innovative products. Hemp: the ultimate triple bottom line crop for people, planet and profits,”   However a research report by a relied upon industry source, (The Brightfield Group) has previously projected that the: “Hemp CBD Market to Reach $22 Billion By 2022: Outpacing the Rest of the Cannabis Market Combined”, so while the projections may differ they agree that the future revenues will rise substantially in the next few years.

The Yield Growth Corp. (CSE:BOSS) (OTCPK:BOSQF) BREAKING NEWS:  Yield Growth Corp enters agreement with consultant Pontier Services to set up Urban Juve hemp beauty products for sales through China’s most popular messaging app, WeChat, and to launch a marketing campaign with a pop-up kiosk to rotate through luxury shopping malls and other major locations in Hong Kong for three months beginning in June 2019.    According to New Frontier Data, in 2017, Chinese hemp sales totaled $1.1 billion, approaching 1/3 of the $3.1 billion global market, with sales forecasted to grow to $1.5 billion (up 36%) by 2020.

The objectives of the pop up kiosk campaign will be to introduce Urban Juve’s brand story, Ayurveda philosophy and proprietary hemp root oil ingredient skin care products to the Chinese audience through the WeChat platform and to drive sampling and sales transactions through the kiosks.   The initial locations for the artificial intelligence enabled kiosk this summer will be 3 luxury shopping malls in Hong Kong, University of Science and Technology, Science Park and the Park Yoho residence clubhouse.

“The use of pop-up kiosks in shopping malls to promote online sales is an innovative way to reach the modern consumer,” says Penny Green, CEO of Yield Growth.  “We are excited to launch Urban June’s hemp products in the fast growing Chinese market this summer through WeChat.”  Urban Juve will be the first Canadian brand to launch PopSquare AI-enabled pop-up kiosks in China.  Through Pontier and PopSquare, Urban Juve will use big data, computer vision, sensor fusion and machine learning to deliver increased sales, deeper analytics and enhanced customer service.   Read this and more news for The Yield Growth Corp. at:  https://www.financialnewsmedia.com/news-boss

Other recent developments from yesterday and major influences in the cannabis/CBD industry include:

The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (OTCQX: TGODF) recently announced that  is pleased that Hamilton City Council has voted to approve the Company’s settlement offer, to allow TGOD to operate its cannabis greenhouse in Ancaster, Ontario upon confirmation of the settlement by the Local Planning Appeal Tribunal at a meeting scheduled for April 25, 2019.

“This is tremendous news for our Company and for the city of Hamilton,” said Brian Athaide, CEO and Director of TGOD. “We are a global company that has its roots in Hamilton, and we are looking forward to expanding our production of high-quality, organic cannabis right here in our home town. This is important to TGOD’s ability to generate considerable near-term revenue while the Company continues to approach its global planned output of 219,000 kgs.”

The Supreme Cannabis Company, Inc. (TSX: FIRE) (OTCQX: SPRWF) recently announced that it expects its previously announced oil products line to be introduced to adult-use consumers in select Canadian markets starting April, 2019.

Supreme Cannabis plans to initially ship oil products to select markets before expanding distribution of its cannabis oil line to additional provinces which is expected by the end of June, 2019. Each bottle will contain a proprietary blend of highly purified cannabis oils and terpenes derived from plants grown by 7ACRES.

OrganiGram Holdings Inc. (TSX-V: OGI) (OTCQX: OGRMF), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis recently announced the recent appointment of strategy and operations consultant James Cavanagh as the Company’s Chief of Staff.

Mr. Cavanagh is an experienced professional who has worked with Canadian and global clients across a variety of industries to drive top and bottom-line growth as well as organizational and operational improvements. Previously with PwC, he has overseen the design and implementation plan of global manufacturing, corporate, and sales processes designed to strategically enhance performance and revenue. Mr. Cavanagh has also facilitated digital strategy development and implementation, introducing new technology platforms in order to improve critical business processes and help achieve cost reduction.

MedMen Enterprises Inc. (CSE: MMEN.CN) (OTCQX: MMNFF) recently announced that it has entered into an equity distribution agreement (the “Equity Distribution Agreement”) with Canaccord Genuity Corp. pursuant to which the Company may, from time to time, sell Class B subordinate voting shares (the “Subordinate Voting Shares”) in the capital of the Company for aggregate gross proceeds of up to CDN$60,000,000 . The At-the-Market equity financing program (the “ATM program”) is designed to enable the Company to issue Subordinate Voting Shares from treasury at lower cost than traditional offerings, without discount and at prevailing trading prices. The Company intends to use the net proceeds from the sale of Subordinate Voting Shares under the ATM program principally for general and administrative expenses, working capital needs and other general corporate purposes.

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates Financialnewsmedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks.  For current services performed FNM has been compensated forty nine hundred dollars for news coverage of the current press releases issued by The Yield Growth Corp. by a non-affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Thursday, April 11th, 2019 Uncategorized Comments Off

$RIV $RIV.V $CNPOF 2019 & Cannabis Companies In North America

Palm Beach, FL – April 11, 2019 – This year 2019 will be the year of maturation and expansion for the cannabis industry. Expectations are high and optimism abounds on all fronts. A recent article in Forbes echoed this optimism: “This new year bodes well for the cannabis industry. There’s excitement as we welcome new states into the cannabis fold and fervent hope that we’ll see movement toward making cannabis fully legal at the federal level. Momentum from several major developments in 2018, including the inclusion of industrial hemp in the new farm bill and Canada’s nationwide legalization, will certainly continue to fuel innovation, policy and entrepreneurship… there’s a lot of enthusiasm and a general expectation that the U.S. is moving toward an end of prohibition at the federal level.  It continued: “This is the year when we’re going to start to see a bifurcation between companies that are solid and those that aren’t. Up until now, cannabis has been a “rising tide lifts all the boats” kind of industry. But that won’t be true anymore. We’ll see people who are successfully executing their business plans get a major lift this year as consumer spending is expected to jump 40%. But we’ll also start to see inept companies fail. A lot of people blindly got into cannabis because it was hot or the next big thing and they’re going to pay a penalty for not knowing the industry. 2019 is going to be a reality check, which is a good thing for those companies that have solid, professional business plans in place, because we can expect retail investors to start to take a back seat to big money.   Active companies in the industry making moves to ready that include:  IONIC Brands Corp., (CSE: IONC), SLANG Worldwide Inc. (CSE: SLNG) (OTC: SLGWF), Plus Products Inc. (CSE: PLUS) (OTC: PLPRF),  Origin House (CSE: OH.CN) (OTC: ORHOF), Canopy Rivers Inc. (OTC: CNPOF) (TSX-V: RIV).

The article concluded: “Stocks were volatile for a few months at the end of 2018 because investors weren’t sure how the landscape would change after Canada’s switch to legal cannabis. But as institutional investors start coming in, they’ll take a hard look at everyone’s numbers and reward companies that are solidly performing and have the traditional hallmarks of a successful startup. That means capital is going to start migrating to the better players, which is going to further separate them from the pack. While there will be some fallout, in general, it’s a good thing for the market. An industry built on hype and expectation can’t survive. This is the year we’re going to see that performance and numbers matter.”

IONIC Brands Corp., (CSE: IONC) BREAKING NEWS:  IONIC Brands is pleased to announce that the Company’s product licensing partner has signed an exclusive distribution agreement with Continuum (“Continuum”) a California Division of  Origin House (“Origin House”) to distribute Ionic branded products.   Ionic branded products are now part of the Origin House distribution platform in California.  Origin House has the largest US footprint of branded and distribution assets in North America.

One of the Continuum strengths is its portfolio of over 30 cannabis brands, which it delivers to more than 500 dispensaries in California. Distribution is a critical part of the cannabis supply chain in California, where the legal cannabis market is expected to hit US$7.7 billion by 2020, according to Arcview Market Research/BDS Analytics.  The agreement also provides further potential access to 10 additional US states including Michigan, Massachusetts, Ohio, Pennsylvania, Illinois, Arizona, and Florida.

Effective immediately Continuum is the exclusive distributor of all Ionic Brands products in California.  Origin House’ Director of Key Supplier Relations, Jessica Lilga commented,“the California cannabis distribution market is very competitive. Continuum has the advantage to distribute the finest products from the best companies and we are excited to offer Ionic products to our customers.  The IONIC team meets our high standards of professionalism and experience, and we are very excited to help build this brand in California and potentially other states as our two companies expand our national footprint.”

IONIC BRANDS Chairman and CEO John Gorst commented that “IONIC BRANDS sought out the top distributor in California and given Origin House’ footprint, Ionic anticipates increased brand awareness, heighten demand for its products, and aggressive sales growth.  Our exclusive distribution agreement with Origin House distributor Continuum aligns with our strategy to build a multi-state consumer-focused cannabis concentrate national brand portfolio focusing on the premium and luxury segments.  We look forward to growing with Continuum as we build the market for our portfolio of premium cannabis branded products.”    Read this entire announcement  for IONC at:     https://www.financialnewsmedia.com/news-ionc/

Additional industry related developments from around the markets:

SLANG Worldwide Inc. (CNSX: SLNG) (SLGWF)  At the request of the Investment Industry Regulatory Organization of Canada, Slang Worldwide Inc. has confirmed that the company’s management is unaware of any material change in the company’s operations that would account for the recent increase in market activity.

The company is presently pursuing a number of acquisition transactions, which transactions are at various stages of development. Any such transaction will be fully disclosed if and at such time as it becomes material information regarding the company.

Canopy Rivers Inc. (OTCPK: CNPOF) (TSX-V: RIV) –  James E. Wagner Cultivation Corp., a portfolio company of Canopy Rivers Inc., has received a cultivation license from Health Canada for its Kitchener-based commercial-scale production facility (JWC2). This second license launches the initial phase of JWC2, a 345,000-square-foot production and distribution complex, where James E. Wagner Cultivation is rolling out more than 130 individual production rooms utilizing its proprietary GrowthStorm dual-droplet cultivation platform and methodologies. With the newly licensed facility located just minutes from James E. Wagner Cultivation’s already licensed pilot facility, James E. Wagner Cultivation is well positioned for an efficient ramp-up and expects to commence cannabis production at JWC2 immediately.

“While optimizing production methodologies at their already licensed pilot facility, JWC has concurrently built out and implemented refinements and learnings for production at commercial scale,” commented Daniel Pearlstein, executive vice-president of strategy at Canopy Rivers. “We are pleased to see Health Canada reward JWC for the quality of their operations and their disciplined approach to expansion with the issuance of this second site licence.”

Plus Products Inc. (CSE: PLUS.CN) (OTCQB: PLPRF) has launched its newest product: mango CBD (cannabidiol) relief, which will contain 4.5 milligrams of cannabidiol and 0.5 mg of tetrahydrocannabinol in each gummy. The new product is already available at some of the more than 250 retailers in California who carry the Plus product line.

The company will retire its previous CBD relief product, “pineapple coconut CBD relief,” as part of a co-ordinated launch campaign with retailers. According to BDS Analytics, pineapple coconut CBD relief was the top selling CBD edible in the California market in Q4 2018 as measured by units and dollars sold.

Origin House (CSE: OH.CN) (OTCQX: ORHOF) – CannaRoyalty Corp d/b/a Origin House  a North American cannabis products and brands company recently provided an update on Sonoma County permit approvals received by the Company’s pending acquiree, California -based cannabis cultivator Cub City LLC (“Cub City”) and wholly-owned subsidiary, FloraCal Farms (“FloraCal”).

Cub City received a Minor Use Permit (“MUP”) from the County of Sonoma for cultivation, processing, non-volatile manufacturing, and distribution at its Santa Rosa facility. The MUP was approved by a unanimous vote of the Sonoma County Board of Zoning Adjustments (the “Board”), following a public hearing on March 28, 2019 . The appeal period for the Board’s decision ended on April 8, 2019 without any appeal being filed.

 

DISCLAIMER:  FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels.  FNM is NOT affiliated in any manner with any company mentioned herein.  FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities.  The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material.  All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks.  All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release.  FNM is not liable for any investment decisions by its readers or subscribers.  Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM has been compensated forty six hundred dollars for news coverage of the current press release issued above by IONIC Brands Corp. by a non affiliated third party.  FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Thursday, April 11th, 2019 Uncategorized Comments Off

$GNPX Featured in NetworkNewsWire Publication on Revolutionary Gene Therapies

New York, New York–(April 11, 2019) – Genprex Inc. (NASDAQ: GNPX) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), a multifaceted financial news and publishing company for private and public entities.

To view the full publication, titled “Potential Blockbuster Gene Therapy Programs to Watch in 2019,” visit: http://nnw.fm/YC9iq

Perhaps no other disease strikes as much dread and fear as cancer. Many successful treatments are available today that didn’t exist just a couple decades ago; however, cancer cells and how they grow remain unpredictable and, in some cases, mysterious. Even after seemingly effective conventional treatments, cancer cells can hide out in some patients and resurface. Genprex Inc. (NASDAQ: GNPX) is pioneering a new approach to treating cancer.

Genprex’s initial product candidate, Oncoprex, is an immunogene therapy for non-small cell lung cancer (NSCLC), one of the most common causes of cancer deaths in the world. About 85% of lung cancers are non-small cell lung cancer. Survival rates for late stage non-small cell lung cancer haven’t improved significantly in over a quarter century. Genprex is in hot pursuit of life-changing gene technologies for patients facing this dismal outlook.

About Genprex, Inc.

Genprex, Inc. is a clinical stage gene therapy company developing potentially life-changing technologies for cancer patients, based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. Visit the company’s web site at www.genprex.com or follow Genprex on Twitter at twitter.com/genprex, Facebook at facebook.com/genprexinc, and LinkedIn at linkedin.com/company/genprex.

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets, (3) enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge. For more information, please visit https://www.NetworkNewsWire.com.

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer.

Forward-Looking Statements

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

Corporate Communications:

NetworkWire (NW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkWire.com

Thursday, April 11th, 2019 Uncategorized Comments Off

$GNPX Potential Blockbuster Gene Therapy Programs to Watch in 2019

NetworkNewsWire Editorial Coverage: Several revolutionary gene therapies appear to be on the verge of delivering remarkable remedies for diseases that have previously been viewed as untreatable.

  • Gene therapy is the next great leap forward in medicine, with several noteworthy programs underway looking to cure the incurable
  • FDA expects 200 new gene and cell therapy INDs in next two years
  • Genprex — and its initial product candidate Oncoprex — is pioneering a new approach to treating cancer.

Built on decades of scientific research and innovation, gene therapy is the next frontier of medicine, determined to provide remedies for previously untreatable diseases and unmet medical needs. At the forefront of this gene therapy revolution, Genprex Inc. (NASDAQ: GNPX) (GNPX Profile) is pioneering a new paradigm in cancer therapeutics. The company’s first target is non-small cell lung cancer, and research indicates that Genprex’s novel technology might also deliver other cancer-fighting genes to combat a variety of different cancers. Sangamo Therapeutics Inc. (NASDAQ: SGMO) is conducting landmark studies to treat hemophilia, inherited metabolic disorders and other serious diseases at the genomic level. uniQure N.V. (NASDAQ: QURE) is leveraging its technology platform to advance a pipeline of proprietary and partnered gene therapies to treat patients with hemophilia, Huntington’s disease and other severe genetic diseases. bluebird bio Inc. (NASDAQ: BLUE) is developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies. And Leap Therapeutics Inc. (NASDAQ: LPTX) is focused on developing…

Read more »

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

DISCLAIMER: NetworkNewsWire (NNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by NNW are solely those of NNW. Readers of this Article and content agree that they cannot and will not seek to hold liable NNW for any investment decisions by their readers or subscribers. NNW is a news dissemination and financial marketing solutions provider and are NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, NNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

NNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and NNW undertakes no obligation to update such statements.

Wednesday, April 10th, 2019 Uncategorized Comments Off

$TCAN Issues Update on Cannabis Facility Acquisition

TransCanna Holdings (CSE: TCAN) (FSE: TH8), an emerging cannabis branding, transportation and distribution company based in Canada, this morning provided an update concerning the company’s acquisition of a 196,000-square-foot vertically integrated cannabis facility. Per the update, TransCanna expects the closing of escrow for the acquisition to take place on or around Monday, April 15th. The company intends to provide an additional update upon the successful completion of the acquisition.

To view the full press release, visit: http://nnw.fm/4jQcu

About TransCanna Holdings Inc.

TransCanna Holdings Inc. is a Canadian-based company focused on providing integrated branding, transportation and distribution services, through its wholly-owned California subsidiaries, to a range of industries including the cannabis marketplace. For more information, visit the company’s website at www.TransCanna.com.

NOTE TO INVESTORS: The latest news and updates relating to TCAN are available in the company’s newsroom at http://nnw.fm/TCAN

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, April 10th, 2019 Uncategorized Comments Off

$VVCIF to Report Fourth Quarter and Full Year 2018 Financial and Operating Results

NAPANEE, ON, April 10, 2019 - VIVO Cannabis Inc. (TSX-V: VIVO, OTCQB: VVCIF) (“VIVO” or the “Company“), a leading provider of premium cannabis products and services for the medical and adult-use markets, today announced the Company expects to issue fiscal fourth quarter and full year 2018 financial and operating results before the markets open on April 30, 2019.

About VIVO Cannabis™

VIVO, based in Napanee, Ontario, is recognized for trusted, high-quality products and services. It holds production and sales licences from Health Canada and operates world-class indoor cultivation facilities with proprietary plant-growing technology. VIVO has a collection of premium brands targeting unique customer segments, including Beacon Medical™, FIRESIDE™, Canna Farms™ and Lumina™. In August 2018, VIVO acquired Canna Farms, a premium cannabis company based in Hope, British Columbia. Canna Farms was B.C.’s first Licensed Producer and has several years of craft cultivation experience and expertise, as well as a significant patient base and positive cash flow. The Company is significantly expanding its production capacity and pursuing partnership and product development opportunities domestically, as well as in select international markets, including Germany and Australia. VIVO also operates Harvest Medicine, a patient-centric and highly scalable network of specialty medical cannabis clinics as well as a free telemedicine app. VIVO has a healthy balance sheet and is well-positioned to accelerate its growth in Canada and internationally.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Wednesday, April 10th, 2019 Uncategorized Comments Off

$TGODF $TGOD Receives Global Recognition for New Website with Two Prestigious Awards

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) on Tuesday announced that its website, TGOD.ca, was recognized with two prestigious global awards. According to the update, the honors include two Horizon Interactive Awards in the categories of “Best Responsive / Mobile Website (Gold)” and “Best E-commerce Website (Bronze).” Since 2002, the Horizon Interactive Awards have recognized the best websites, videos, online advertising, print media and mobile applications, judging thousands of entries from around the world based on design, creativity, technical approach, clarity of message and overall effectiveness. “We are thrilled to receive global recognition for our new site,” TGODF CEO Brian Athaide said in the news release. “Having launched in only December 2018, the fact that we are already receiving awards is remarkable. This recognition showcases the importance of not only building a leading digital platform for the cannabis industry, but a platform that competes across all industries.”

To view the full press release, visit: http://nnw.fm/IW9Nc

About the Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. The company grows high-quality, organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://nnw.fm/TGODF

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Wednesday, April 10th, 2019 Uncategorized Comments Off

$VVCIF The Most Prevalent Cannabis E-commerce Platforms in Canada

VANCOUVER, British Columbia, April 09, 2019 — Cannabis e-commerce platforms, both medical and recreational, are becoming increasingly important as Canada’s legal marijuana market matures.

However, given that only two of Canada’s ten provinces—Manitoba and Saskatchewan—currently allow private marijuana retailers to sell cannabis online, online medical marijuana stores have continued to reign supreme in Canada’s online cannabis market.

To get a better understanding of how Canada’s online marijuana market is developing, we take a closer look at some of Canada’s most promising medical and recreational cannabis e-commerce platforms.

Westleaf

Westleaf Inc. (TSX-V: WL) (OTCQB: WSLFF), a vertically integrated Canadian cannabis company focused on innovative retail experiences as well as cultivation, production and extraction of cannabis products, and set to become one of Canada’s largest premium cannabis retailers, recently launched its Prairie Records cannabis e-commerce platform for online sales Saskatchewan.

Via Westleaf,

“The launch of online retail is an important next step in rolling out the Prairie Records brand across Saskatchewan and the rest of Western Canada over the coming months,” said Scott Hurd, President and CEO of Westleaf.

“The province of Saskatchewan has proven to be a positive regulatory environment to launch our retail operations and we are pleased it is the first jurisdiction with a Prairie Records online presence.”

Prairie Records is Westleaf’s unique cannabis retail concept, which seeks to redefine the cannabis purchasing experience through tactile in-store features and product offerings that celebrate the relationship between music and cannabis.

Momentum behind Westleaf’s Prairie Records retail expansion certainly seems to be building—the Company recently announced that two new Prairie Records stores are set to open by April 20, 2019 in Saskatoon.

Via Westleaf,

Saskatoon and all of Saskatchewan, is proving to be one of the strongest cannabis retail markets in Canada as the sector continues to evolve and mature,” says Scott Hurd, President and CEO of Westleaf.

“We have the opportunity to deal directly with licensed producers in stocking our shelves, we are able to sell online across the province through our e-commerce platform, and the ratio of stores to market size make Saskatoon an ideal location to operate cannabis retail.”

With additional stores planned for British Columbia, Alberta, Saskatchewan, and potentially Ontario, Westleaf is currently aiming to rollout up to 50 Prairie Records stores across Canada.

Fire & Flower

Fire & Flower Holdings Corp. (TSX-V: FAF), an independent licensed cannabis retailer, announced last month that it had launched its e-commerce platform to sell adult-use recreational cannabis to customers in the province of Saskatchewan and accessory products to customers across Canada.

Via Fire & Flower,

“The e-commerce platform was developed by Fire & Flower’s digital product studio, HiFyre Inc., that was acquired by Fire & Flower in July of 2018. HiFyre Inc. has significant cannabis experience working in the legal cannabis industry for the past six years with clients including Mettrum Health Corp., Starseed Medicinal Inc. and Canopy Growth Corporation.

In tandem with its foray into online recreational cannabis sales, Fire & Flower recently announced the opening of its first Fire & Flower branded store in Ontario. Fire & Flower’s Ontario location marks the company’s tenth licensed cannabis retail store in Canada.

Canopy Growth

Canopy Growth Corp. (TSX: WEED) (NYSE: CGC), the world’s largest cannabis company, serves 83,000+ medical marijuana patients across Canada through its Spectrum Cannabis e-commerce platform. Canopy Growth also appears to have plans for a Tweed online store, which may foreshadow the company’s entry into the online recreational cannabis market.

In recent news, Canopy Growth continues to bolster its product offerings—online and otherwise—through a partnership with Houseplant, Seth Rogen and Evan Goldberg’s new cannabis brand.

Via Canopy Growth,

“Under the terms of the partnership, Houseplant will lean on the production and distribution capabilities of Canopy Growth and its licensed subsidiaries to ensure an ample supply of Houseplant flower, Softgel, and pre-rolled formats are rolled out in Canada over the coming months.”

Aphria

Aphria Inc. (TSX: APHA) (NYSE: APHA), a leading global cannabis company driven by an unrelenting commitment to people, product quality and innovation, has one of the most established medical cannabis e-commerce platforms in Canada.

According to the company’s corporate presentation dated Q1 2019, Aphria has sold over 8,700 kg of marijuana since 2014 through its online medical cannabis platform. Moreover, Aphria boasts an award-winning patient care team and diverse online product portfolio, including 30+ dried flower products and 7 activated cannabis oil products.

In order to ensure that it can keep up with the growing demand of Canada’s medical and recreational cannabis consumers, Aphria continues to expand its production capabilities. The company recently announced that “Health Canada had granted the Company its license amendment, permitting Aphria to commence production in an additional 800,000 square feet of facilities at its Aphria One location.

Via Aphria,

“This is a major milestone for Aphria on its path to becoming a leading global cannabis producer, as well as a positive development greatly anticipated by the Canadian cannabis industry,” said Irwin D. Simon, Interim CEO of Aphria.

“Aphria’s progress expanding production and automation is essential to our strategy of securing scale and long-term advantages that enable the evolution of the cannabis industry through product and brand innovation. With Aphria One, we now have the ability to expand our production capacity by over three times.

VIVO Cannabis

Last month, VIVO Cannabis Inc. (TSX-V: VIVO) (OTCQX: VVCIF), a licensed cannabis producer offering premium medical and adult-use products and services, announced that it was launching an online medical cannabis store through its wholly-owned subsidiary, Canna Farms Limited.

Via VIVO Cannabis,

“Canna Farms’ integrated online store will cater to discerning medical cannabis consumers,” said Daniel Laflamme, President of Canna Farms.

“In addition to offering award-winning Canna Farms and Beacon Medical brands, the site will serve as a marketplace for products from other licensed producers who share VIVO’s commitment to delivering premium products and services focused on health and wellness.”

In addition to the launch of Canna Farms’ online medical cannabis store, VIVO also announced that Canna Farms had received approval from Health Canada to double its cultivation capacity in British Columbia and Ontario. Considering that Canna Farms’ e-commerce site carries “more than 40 different cannabis strains and 100 different SKUs,” this increased production capacity will likely come in handy as Canna Farms’ online product offerings continue to increase.

Canadian Cannabis E-Commerce Stifled By Provincial Regulations

With a number of Canada’s provinces restricting private cannabis retailers from selling marijuana online, online recreational cannabis sales currently have limited potential in Canada. These strict regulations, when combined with the small addressable markets of Manitoba and Saskatchewan, reinforce the necessity of a strong cannabis retail brand.

Still, the market for online recreational cannabis sales in Canada could become vital—much like the online medical cannabis market today—should other Canadian provinces embrace recreational cannabis e-commerce.

The original post can be found here: https://mugglehead.com/canadian-cannabis-ecommerce-platforms/

Disclosure: Directors of Mugglehead own shares of Westleaf Inc. and other marijuana stocks not mentioned in this release and we have been compensated by Westleaf for news coverage.

About Mugglehead

Mugglehead.com is a digital publisher dedicated to cannabis news, investments, culture, and science, owned by Mugglehead Media Corp. We publish original content, including video, interviews and articles. Because many of the companies and trends we cover are related to investments and stocks within the cannabis industry, please review our disclaimer and forward-looking statements below.

Original content created by Mugglehead Media Corp. © 2019 is protected by copyright laws.

For interviews, advertising opportunities, and coverage requests – including brand and product reviews – contact us at: muggle (at) mugglehead.com

We have lots in store for 2019 so be sure to check us out!

Visit us at https://mugglehead.com daily for all things cannabis-related.

Facebook: https://www.facebook.com/muggleheadmedia

Twitter: https://twitter.com/muggleheadmedia

Disclaimer and Forward-Looking Statements

Mugglehead Media Corp. and Mugglehead.com (collectively, Mugglehead) is a news and media publisher dedicated to cannabis. It is not registered as an investment adviser, broker-dealer or other financial or securities professional with any financial or securities regulatory authority. You understand that no content published by Mugglehead constitutes a recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person. Mugglehead does not render general or specific investment advice and does not endorse or recommend the business, products, services or securities of any industry or company mentioned on this Site.

It is not intended to provide tax, legal, insurance or investment advice, and nothing on in this release should be construed as an offer to sell, a solicitation of an offer to buy, or a recommendation to buy or sell any security. None of the content we publish is provided with a view to inviting, inducing or encouraging any person to make any kind of investment decision. You are solely responsible for determining whether any investment, security or strategy, or any other product or service, is appropriate or suitable for you based on your investment objectives and personal and financial situation. You should consult an attorney or tax professional regarding your specific legal or tax situation. You should also consult a licensed professional, such as a financial advisor or broker-dealer, when dealing in any securities or making any investment decisions. We do not guarantee that any of the companies mentioned on Mugglehead.com or any of our newsletters or content will perform as we expect, and any comparisons we have made to other companies may not be valid or come into effect.

This news release is not an offer to sell or a solicitation of an offer to buy any securities or commodities. To the extent that anything in this press release may be deemed to be investment advice or a recommendation in connection with a particular company or security, such information is impersonal and is not tailored to the needs of any specific person.

You understand that an investment in any security is subject to a number of risks, and that discussions of any security published on the Site will not contain a list or description of relevant risk factors. In addition, some of the securities about which content is published by us have a low market capitalization, insufficient public float and/or are thinly traded. Such securities are subject to more risk than securities of larger companies, including greater volatility, lower liquidity and less publicly available information. Content we publish may have an effect on the price of such securities.

From time to time, Mugglehead (on behalf of itself and any partner, director, officer or insider of Mugglehead) may have a financial or other interest in the party or parties featured in this release, within the meaning of National Instrument 31-103 – Registration Requirements, Exemptions, and Ongoing Registrant Obligations, published by the Canadian Securities Administrators, as a result of ownership of securities in, compensation received or receivable from or other financial arrangement with such party or parties featured in this press release. We will disclose if we have a position in any such party or parties, as at the date of publication of this press release; however, we may not update this disclosure after such date. We have been compensated CAD$10,500 per month for 12 months (total $126,000) by Westleaf Inc. for news coverage and our directors own shares of Westleaf Inc.

In addition to historical information, this press release may contain forward-looking statements, including statements with respect to third parties regarding product plans, future growth, market opportunities, strategic initiatives, industry positioning, customer acquisition, the amount of recurring revenue and revenue growth. In addition, when used on the Site, the words ”will,” ”expects,” ”could,” ”would,” ”may,” ”anticipates,” ”intends,” ”plans,” ”believes,” ”seeks,” ”targets,” ”estimates,” ”looks for,” ”looks to,” ”continues” and similar expressions, as well as statements regarding a third party’s focus for the future, are generally intended to identify forward-looking statements. Each of the forward-looking statements we make in this press release involves risks and uncertainties that may cause actual results to differ materially from these forward-looking statements. Factors that might cause or contribute to such differences include, but are not limited to, those disclosed by the companies featured in this release in their public securities filings. You should carefully review the risks described therein. You should not place undue reliance on these forward-looking statements, which speak only as of the date such statement was published. Mugglehead undertakes no obligation to publicly release any updates or revisions to the forward-looking statements or reflect events or circumstances after the date of their publication, except as required by law.

From time to time, reference may be made in this press release to prior articles or opinions we have published. These references may be selective, may reference only a portion of an article or opinion, and are likely not to be current. As market information changes continuously, previously published information and data, and any references thereto, may not be current and should not be relied upon.

If you ever have any questions or concerns about our business or publications, we encourage you to contact us.

For interviews, advertising opportunities, and coverage requests - including brand and product reviews - contact us at: muggle (at) mugglehead.com
Tuesday, April 9th, 2019 Uncategorized Comments Off